BioSpace News Archive

Business

OMass Therapeutics Expands Leadership Team with Two New Appointments

OMass Therapeutics, a biotechnology company that identifies medicines against highly validated target ecosystems, announces the expansion of its leadership team with the appointment of two senior executives in newly created roles.

August 2, 2023
·
4 min read
InDex Pharmaceuticals has been granted a new patent in Europe for the commercial formulation of cobitolimod

InDex Pharmaceuticals Holding AB announced that a new formulation patent for the drug candidate cobitolimod has been granted by the European Patent Office.

August 2, 2023
·
2 min read
Pharm Country

Molecular Targeting Technologies, Inc. and Molecular Theranostics Center of Singapore Receive HSA Approval for Clinical Trial Authorization for EBTATE® in Nasopharyngeal Cancer

Molecular Targeting Technologies, Inc., and its wholly owned subsidiary, Molecular Theranostic Center of Singapore, announced the approval of a Clinical Trial Authorization application by the Health Sciences Authority of Singapore.

August 2, 2023
·
2 min read
Business

United Therapeutics Corporation Reports Second Quarter 2023 Financial Results

United Therapeutics Corporation, a public benefit corporation, announced its financial results for the quarter ended June 30, 2023.

August 2, 2023
·
11 min read
Business

SpringWorks Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights

SpringWorks Therapeutics, Inc. reported second quarter financial results for the period ended June 30, 2023 and provided an update on recent company developments.

August 2, 2023
·
14 min read
Pharm Country

Matinas BioPharma to Participate in the BTIG Virtual Biotechnology Conference 2023

Matinas BioPharma Holdings, Inc. announces that Jerome D. Jabbour, Chief Executive Officer, will hold meetings with institutional investors during the BTIG Virtual Biotechnology Conference 2023 being held August 7-8, 2023.

August 2, 2023
·
4 min read
Genetown

Voyager Therapeutics to Present at the Canaccord Genuity Growth Conference

Voyager Therapeutics, Inc. today announced that Chief Scientific Officer Todd Carter, Ph.D., and Chief Financial Officer Peter Pfreundschuh will participate in a Fireside Chat at the Canaccord Genuity 43rd Annual Growth Conference on Thursday, August 10, 2023, at 10:30 a.m. ET.

August 2, 2023
·
1 min read
Business

AmerisourceBergen Reports Fiscal 2023 Third Quarter Results

AmerisourceBergen Corporation reported that in its fiscal year 2023 third quarter ended June 30, 2023, revenue increased 11.5 percent year-over-year to $66.9 billion.

August 2, 2023
·
49 min read
Business

EyePoint Pharmaceuticals Reports Second Quarter 2023 Financial Results and Highlights Recent Corporate Developments

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to improve the lives of patients with serious eye disorders, today announced financial results for the second quarter ended June 30, 2023 and highlighted recent corporate developments.

August 2, 2023
·
13 min read
Business

Cara Therapeutics to Present at the Canaccord Genuity 43rd Annual Growth Conference

Cara Therapeutics, Inc. today announced that Christopher Posner, President and Chief Executive Officer, will present at the Canaccord Genuity 43rd Annual Growth Conference on Wednesday, August 9, 2023, at 8:00 a.m. EDT in Boston, MA.

August 2, 2023
·
1 min read